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Abstract
Background: Induction of labour (IOL) is one of the most commonly performed interventions in maternity care,
with outpatient cervical ripening increasingly offered as an option for women undergoing IOL. The COVID-19
pandemic has changed the context of practice and the option of returning home for cervical ripening may now
assume greater significance. This work aimed to examine whether and how the COVID-19 pandemic has changed
practice around IOL in the UK.
Method: We used an online questionnaire to survey senior obstetricians and midwives at all 156 UK NHS Trusts
and Boards that currently offer maternity services. Responses were analysed to produce descriptive statistics, with
free text responses analysed using a conventional content analysis approach.
Findings: Responses were received from 92 of 156 UK Trusts and Boards, a 59% response rate. Many Trusts and
Boards reported no change to their IOL practice, however 23% reported change in methods used for cervical
ripening; 28% a change in criteria for home cervical ripening; 28% stated that more women were returning home
during cervical ripening; and 24% noted changes to women’s response to recommendations for IOL. Much of the
change was reported as happening in response to attempts to minimise hospital attendance and restrictions on
birth partners accompanying women.
Conclusions: The pandemic has changed practice around induction of labour, although this varied significantly
between NHS Trusts and Boards. There is a lack of formal evidence to support decision-making around outpatient
cervical ripening: the basis on which changes were implemented and what evidence was used to inform decisions
is not clear.
Keywords: Induction of labour, Cervical ripening, COVID-19, Choice
Introduction
Induction of labour (IOL) is one of the most commonly
performed interventions in maternity care, experienced
by around 30.6% of pregnant women in the UK [1, 2].
Cervical ripening is a key component of IOL [3],
whereby application of a drug or mechanical method
over a number of hours causes softening, shortening,
and opening of a woman’s cervix in preparation for
labour. Cervical ripening is recommended by NICE for
everyone undergoing IOL [4].
Traditionally women undergoing cervical ripening are
asked to remain in hospital throughout the procedure to
allow maternity care staff to monitor their wellbeing and
that of their baby. However, outpatient cervical ripening
(commonly referred to as home cervical ripening) is in-
creasingly being offered as an option, enabling women
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to choose to attend hospital for an initial assessment and
administration of cervical ripening agent; and then to re-
turn home for a period of time (usually 24 h), before
returning to hospital to be reassessed. Home cervical
ripening appears to be safe and feasible, but at present
there is lack of evidence to guide decision-making about
where cervical ripening should happen [5, 6]. The
CHOICE Study, a UK-wide NIHR-funded prospective
cohort study and process evaluation, aims to determine
whether outpatient cervical ripening during induction of
labour is safe, effective and cost effective [7]. A qualita-
tive component of the CHOICE Study, qCHOICE, will
also consider the acceptability of home cervical ripening
to women and their families.
In March 2020, the World Health Organisation
(WHO) declared the novel coronavirus (COVID-19)
outbreak a global pandemic. Subsequently, in an attempt
to control the virus, the UK government imposed na-
tional restrictions on movement and social contact:
across the National Health Service (NHS) this changed
how, when and where people received their maternity
care [8]. For women this has resulted in reduced choice
about place of birth and restrictions on birth partners
accompanying them when they attend hospital, even
during labour and birth [9]. Within the context of these
sudden, substantial and often distressing changes to ser-
vice provision, the offer to return home after cervical
ripening may have assumed new significance for women
and their health care professionals when making deci-
sions about childbirth.
The CHOICE Study commenced in early 2020, and
changes to practice in response to the pandemic inev-
itably alter the context in which the study will be
conducted. It is important to understand changes in
policy and practice surrounding IOL to inform the
CHOICE study, and other research, and to under-
stand how health care professionals can best support
women who are making decisions about their induc-
tion of labour. Consequently, the CHOICE Study
team conducted a survey of UK maternity services in
order to establish whether and how the pandemic has
changed practice around induction of labour in the




This survey aimed to determine whether aspects of prac-
tice and policy had altered in response to the pandemic.
The research team carefully considered the process of
IOL, with a focus on cervical ripening, and key elements
of that process formed the basis of a questionnaire. The
questionnaire comprised fixed response questions, with
free-text boxes requesting additional detail, allowing
respondents to provide written comments about key
issues.
Women’s experience of the IOL process is vital, and
although it was beyond the scope of this work to ask
their views directly, the survey did endeavour to deter-
mine perceived changes in women’s response to IOL.
All NHS Trusts and Boards in the UK that offer ma-
ternity services were identified through the NHS service
directories for the four UK countries (n = 157). Senior
midwifery and obstetric staff at those Trusts and Boards
were contacted by email through established networks
including the RCM Heads of Midwifery network, profes-
sional contacts of CHOICE Study team; local Clinical
Research Networks; and the British Intrapartum Care
Society. This strategy intentionally focussed on maximis-
ing response rates from senior level clinicians who have
good understanding of local policy and practice, re-
gardless of their profession. The questionnaire was
hosted by Online Surveys (www.onlinesurveys.ac.uk),
and a Microsoft Word version was available should
the respondent have difficulties accessing the online
survey site. The survey was open between June 2020
and November 2020.
Data analysis
Responses were identified according to NHS Trusts and
Boards, as opposed to individual maternity units, and
where duplicate responses were received those were
compared and one combined response created. All UK
Trusts and Boards currently offering maternity services
(n = 156) was used as the denominator to calculate re-
sponse rate.
Responses were exported from the survey site into
IBM SPSS Statistics 23 software and descriptive statistics
were produced in relation to the key issues. Free-text re-
sponses were analysed using a conventional content ana-
lysis approach to determine what themes are present
and how often they reoccur in the data [10]. This ap-
proach was employed, as it is more phenomenological in
nature, best suited for research on a topic where there is
limited pre-existing literature. Preconceived codes and
categories are not used; they instead ‘flow’ from the data.
Each line of free-text responses was coded, and the
resulting codes were grouped into categories and sub-
categories, creating “meaningful clusters” (10, p1279). In
order to establish the validity and credibility of the con-
tent analysis, emergent categories were triangulated with
the descriptive statistics outcomes.
Ethical approval
Ethics approval was obtained from the York & Humber
– Sheffield Research Ethics Committee in June 2020
(IRAS: 276788) as part of the wider CHOICE Study ap-
plication. The survey was initiated in response to
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Committee questions about the impact of COVID-19 on
IOL during the Proportionate Review. Respondents re-
plied on behalf of their organisation and returning a
completed survey was considered implied consent.
Findings
One hundred and fifty-seven UK NHS Trusts and
Boards that currently offer maternity services were iden-
tified. One maternity unit had suspended all services due
to the pandemic making 156 Trusts and Boards eligible
for inclusion. Completed responses were received from
92 of the 156 (59%). A breakdown of response by UK
countries is shown in Table 1. The survey was most
often completed by a Senior Midwife or a Consultant
Obstetrician (Table 2).
Two hundred and fifty-five unique, free-text responses
were collected across 11 survey questions. Three key cat-
egories were identified from the content analysis: IOL
practice, Changes to IOL practice and Changes in IOL
uptake, within which there were several sub-categories
(Tables 3, 6 & 7).
IOL practice
The mean reported induction rate across all responding
Trusts and Boards was 34%. Figure 1 shows the reported
rate in the past year across all responding units. The
mean date at which induction of labour was routinely of-
fered for reason of gestational length was 10 days after
term (40 weeks + 10 days).
Ninety (98%) Trusts and Boards reported using
pharmaceutical methods, such as Propess (PGE2), for
cervical ripening, and 64 (70%) mechanical methods, in-
cluding Cooks balloon and Dilapan-S. At most Trusts
and Boards, 74 (80%), both midwives and obstetricians
conducted cervical ripening. This collaboration was
reflected in the free-text responses, although respon-
dents reported a generally midwifery-led practice
(Table 3).
Changes in IOL practice due to COVID-19
A majority of Trusts and Boards reported no change to
their IOL rates and practice in response to the pan-
demic. For those that did, the survey determined
significant change to key aspects of IOL practice
(Tables 4 & 5).
Twenty-one (23%) Trusts and Boards stated the
methods used for cervical ripening had changed in re-
sponse to the pandemic, while 69 (75%) were un-
changed. We asked respondents to provide details of
changes: most often they reported a switch to mechan-
ical methods, but there was little information provided
about why that was the case. Switching to use of
Dilapan-S as a method of cervical ripening was notable,
and often was mentioned in relation to participation in
the SOLVE trial [11] (Table 6).
Eighty-five (92%) reported no change in the profes-
sional undertaking cervical ripening, six units (7%) did
report change, and one response was missing. Within
the free-text responses explaining changes, the six re-
spondents most often noted that obstetricians had taken
over responsibility for the procedure, and this appeared
to be linked to change in the method being used, with
obstetricians receiving training for the change ahead of
midwives (Table 6).
Though 86 (93%) Trusts and Boards stated no change
in approach regarding IOL for gestational age in re-
sponse to the pandemic, the services that did change re-
vealed sometimes dramatic shifts in practice. For
instance, one island maternity unit noted increased re-
luctance among women to travel to the tertiary unit on
the mainland during the pandemic. This meant that
people normally considered to be at higher risk, for ex-
ample those with a raised BMI or of age 40 and older,
were now offered postdates induction of labour at the is-
land obstetric unit instead of being flown to the
mainland.
Impact on home cervical ripening
Prior to the pandemic, 50 (54%) of Trusts and Boards of-
fered women the option to return home after insertion
of pessary or device for cervical ripening, while 42 (46%)
did not offer the option. Thirty nine of the 50 (78%)






England (130) 71 (55%)
Scotland (14) 14 (100%)
Wales (7) 4 (57%)
Northern Ireland (5) 3 (60%)
UK Total (156) 92 (59%)
Table 2 Work role of person who completed the survey
Work role of person completing the survey n
Senior Specialist Midwife or Midwifery Manager 31
Consultant Obstetrician 25





Obstetric Trainee (ST7) 1
Total 112a
aSome responses stated that two or more people had completed the
survey together
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respondents from units that offered home cervical ripen-
ing stated that only certain categories of women are of-
fered this option. Being categorised as ‘low risk’ was the
most frequently mentioned criteria for offering women
this choice.
The stated criteria for offering home induction varied
across the Trusts and Boards, and in some cases, sug-
gested that eligibility was limited (Table 3). The most
common criteria included post-dates, maternal choice,
absence of clinical indicators of risk (e.g. history of re-
duced fetal movements, increased BMI, maternal age
over 40 years, maternal medical conditions, fetal medical
concerns). The option was also reportedly offered to
women who had balloon catheter, were on a midwifery-
led pathway or planned to give birth in a midwifery unit.
Other responses noted that women’s personal circum-
stances also influenced the availability of this option for
women. Personal criteria for eligibility included living
Table 3 Outcomes from free-text response content analysis -IOL practice
Category Sub-category Examples from data
IOL practice OP IOL eligibility was limited “Low risk post-dates induction living within 20min drive of the hospital.”
“Post-dates (40 + 12 days), Midwifery led care pathway Age between 18 and
40 BMI < 35 Lives within 1 h of hospital Singleton pregnancy No medical or
obstetric history/ complications No more than 4 previous births”
“In order to be suitable for outpatient IOL, the woman must meet the following
criteria: under midwifery-led care during the pregnancy; aged 18–39; primigravid;
BMI 18–34; gestational age of 41 + 1–41 + 6”
“Low risk T + 10–14; live within 30 min of the hospital and have their own transport.
Induction for post dates only with normal liqor volume and otherwise low risk.”
“Multips who live within 30mins of the consultant unit with no history of reduced
FM & low risk. Low risk post-dates primips”
Midwife-led IOL “inserted by the midwife after obstetric review. In case of difficulty, the obstetricians
get involved.”
“Midwives do the in-patients, doctors currently do the out-patient inductions -but it
is becoming more accepted and I think that will change.”
“Obstetricians insert Dilapan currently.” “Midwives insert Prostin/Propess.”
Fig. 1 Reported rate of IOL per unit in the past year
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with 20–60 min by car from hospital, having access to a
phone or own transport, having another adult present at
home and being able to communicate effectively with
staff.
Twenty-six (28%) Trusts and Boards reported that cri-
teria for offering home IOL had changed in response to
the pandemic, 60 (65%) that it had not changed. There
were six missing responses. Overall, respondents re-
ported that more women are being discharged home for
cervical ripening (Table 5). Comments were more likely
to describe a shift towards offering home cervical ripen-
ing, often linked to a change in method from pharma-
ceutical to mechanical. When a change in policy for
offering home cervical ripening had been in progress
prior to the pandemic, some respondents reported the
process of introduction being either accelerated or
halted. A small number noted that they had stopped of-
fering women the opportunity to return home after
commencing cervical ripening, one stating that this was
in an effort to reduce multiple attendance at hospital by
patients and their visitors.
Women’s responses to IOL as reported by staff
Twenty-two (24%) of respondents noted a change in
women’s responses to recommendations for IOL in rela-
tion to gestational age in light of the pandemic. Seventy
(76%), had not noted a change. Free-text responses indi-
cated that changes in IOL uptake were mostly related to
women’s reluctance to the procedure, partner restric-
tions and desire to stay home or local (Table 7).
The responses suggest that women’s reluctance to IOL
was related to less uptake or delay of the procedure, and
that decisions were interlinked with restrictions on birth
partners accompanying them during a hospital stay.
Interestingly, it was more often reported that women
opted to decline or delay induction of labour, rather
than opt for home cervical ripening. There were further
reports of women requesting elective caesarean section
rather than IOL and of fewer requests for IOL before
clinical indications. Declined or delayed IOL was also
connected, by respondents, to local increases in planned
home birth rates.
The survey also asked if there had been a change in
women’s response to offer of home cervical ripening in
relation to the pandemic. There were 20 missing re-
sponses to this question; of those who provided an an-
swer, 23 (32%) respondents reported that more women
wanted home IOL, two that fewer women wanted out-
patient IOL, and 47 (65%) that there had been no
change. Comments around this again indicate that
women preferred to delay or avoid IOL altogether, and
that the shift to outpatient IOL was clinician-driven ra-
ther than service user-driven.
Discussion
The survey was completed by senior midwives and ob-
stetricians at a large proportion of UK NHS Trusts and
Boards and provides important insight to current prac-
tice surrounding induction of labour, as well as how that
has changed in response to the COVID-19 pandemic.
We found that over half of NHS Trusts and Boards of-
fered home cervical ripening prior to the COVID-19
pandemic, that 28% had changed their criteria for offer-
ing home cervical ripening in response to the pandemic,
and that almost a third now report more women going
home after having this procedure. This shift towards
home cervical ripening was accompanied by an apparent
move towards using mechanical methods, such as bal-
loon catheter and Dilapan-S, which were often consid-
ered safer and more acceptable for use at home than
more established pharmaceutical methods. Conversely,
some Trusts and Boards withdrew their home cervical
ripening service.
Although the survey found significant changes in prac-
tice at some Trusts and Boards, this was not perhaps as
great as might be expected given the context of the sub-
stantial changes imposed to service provision in order to
limit physical contact at national level. The diversity of
responses between Trusts and Boards may be due in
part to varying geographies and populations as well as
different experiences of the pandemic. However, the sur-
vey respondents often linked policy decision-making to
those restrictions that were imposed across NHS
Table 4 Significant change to key aspects of IOL practice




Has there been a change in method used for cervical ripening? 21 (23%) 69 (75%)
Has there been a change in professional undertaking cervical ripening? 6 (7%) 85 (92%)
Has there been a change in approach for post-dates induction of labour? 5 (6%) 86 (93%)
Has there been a change in criteria for offering home cervical ripening? 26 (28%) 60 (65%)
Table 5 Change in number of women returning home after










26 (28%) 5 (5%) 56 (61%) 7 (%)
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services in response to the pandemic, particularly the
impetus to minimise hospital admission and length of
stay, and restrictions on birth partners accompanying
women to hospital. At present there is little evidence to
support home versus hospital cervical ripening or the
methods used to achieve it [5, 6] and decision-making
around changes to practice seem likely to have been
driven by immediate need to reduce physical contact in
response to the pandemic. Recent professional scrutiny
and reflection recognises that some changes that were
made were unnecessary and potentially harmful, and re-
vised guidance concerning service level response to the
pandemic has now been issued [12]. It is not clear
whether the changes in policy and practice found in this
survey are permanent or whether they will be subject to
further scrutiny, either in response to guidance from ob-
stetric and midwifery professional bodies or when
COVID-19 is no longer a factor in service provision.
Interestingly, some respondents reported an impres-
sion that the pandemic had improved efficacy of clinical
decision-making and support among clinicians for
change, and this seems to be corroborated by the signifi-
cant amount of change in policy observed to have hap-
pened in a relatively short space of time. The changes
made during this short period were substantial and var-
ied: introducing home cervical ripening where it had not
previously been considered; accelerating introduction
when a service had been under consideration; or stop-
ping an already running home cervical ripening service.
These are complex and multi-faceted changes to policy
and practice, demonstrating that changes which often
take considerable time to implement can be fast-tracked
when there is an urgent need to do so. However, it does
not provide insight to the decision-making process or to
the quality of decisions that were made.
Respondents often mentioned external factors as influ-
encing service provision. Participation in the SOLVE
trial [11] (a randomised control trial comparing Dilapan-
S rods with Propess pessary) was frequently mentioned
as the driver for introduction of a home induction ser-
vice, and conversely pausing the SOLVE trial in response
to the pandemic led to withdrawal of home cervical rip-
ening service in some areas. Staff training, particularly in
use of mechanical methods of cervical ripening, also in-
fluenced whether a service was made available. In most
Trusts and Boards both obstetricians and midwives con-
ducted cervical ripening, but many noted that either only
obstetricians or only midwives had received training in
Table 6 Outcomes from free-text response content analysis -changes to IOL practice
Category Sub-category Examples from data
Changes to IOL
practice
More OP IOL offered “Pregnant women deemed low risk are offered out patient induction. Criteria for induction
changed. Softer reasons such as Social / maternal age are reviewed.”
Changes to IOL methods
and process
“We brought forward the mechanical ripening and ALL women who had Dilapan were
offered home. Dilapan introduced, expectation that women will go home during Dilapan
ripening.”
“We are very keen to offer birth in a FMLU following OIOL but do not have enough data
locally to support this until OIOL births numbers increase on our AMLUs”
Increased OB presence “Initially only obstetricians trained to use balloon catheter. Midwives are now being trained
to conduct balloon catheter IOL]”
“Doctors still doing Dilapan. Midwives mostly doing prostaglandins. More obstetric involvement
as Dilapan training not yet rolled out to midwives.”





“More reluctant for IOL and possibly more women requesting homebirth, due to partner visiting
restrictions and fear of being alone on the antenatal ward”
“Some women have declined, citing Covid as the reason, preferring to stay at home and await
onset of labour.”
“Potentially a few more wanting to wait until after 40 + 7 if they want a home birth (upto 40 + 14)
to avoid hospital attendance. Only very small numbers though.”
Partner restrictions
impact OP uptake
“Partners cannot for IOL process which has caused concerns with the women”
“Women do not want to undergo an IOL without the support of their birth partner whilst receiving
cervical ripening on the antenatal ward. This has created a lot of challenges during the pandemic
with visiting restrictions.”
“Many women have asked to stay at home with their partner rather than being admitted to the
hospital.”
Staying home or local “More women wanting home birth and therefore avoiding IOL”
“We are considering alternative methods of IOL - including mechanical at present, delayed by
pandemic while other things are focus. Women are perceived as slightly more keen to have
outpatient IOL”
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insertion of balloon catheters or Dilapan-S, and that this
affected whether home cervical ripening was available to
women. Inconsistency in this area may reflect lack of
evidence about the use of mechanical methods, ultim-
ately creating difference in the options available to
women depending on where they access care.
Women’s response to induction of labour is also re-
ported to have changed, and this was most often linked
to restrictions on birth partners accompanying them to
hospital. Women were observed as adapting their
decision-making, most notably by choosing alternatives
to induction of labour that might reduce the amount of
time they spend in hospital. In some cases, it appears
that women’s power to choose was increased: as criteria
for induction of labour changed options that were previ-
ously deemed unsafe or lacking in evidence became ac-
ceptable, including women who can now opt for
induction at their home island obstetric unit, or those
who now have the option to return home for cervical
ripening when they could not before. However, it also
appears that for some women decisions were primarily
motivated by fear of being alone during labour and
birth.
In some Trusts and Boards, the option of home cer-
vical ripening was unavailable to women because the
service was withdrawn, and when it was offered ability
to choose this option was severely limited through im-
position of eligibility criteria. It is notable that the
women most likely to be denied the option of home cer-
vical ripening are those who may already feel margina-
lised within maternity services: women categorised as
‘high risk’; women affected by poverty; women whose
first language is not English; and women with disabilities
that alter their ability to communicate. Current evidence
on women’s experiences of home IOL is limited [13],
but the research to date indicates its potential benefits
for women as compared with the in-hospital experience
[14]. Given the general paucity of research on home
IOL, the qCHOICE study (NIHR127569) will explore
women’s, partners’ and healthcare professionals’ experi-
ences and perceptions of home cervical ripening in more
depth.
Conclusion
It is clear from this research that the pandemic has
changed practice around IOL, although the response
varied significantly between NHS Trusts and Boards.
There is a lack of formal evidence to support decision-
making around home cervical ripening, and the basis on
which changes were implemented and what evidence
was used to inform decisions is not clear. This affirms
disparity and inequity of choice for women who are of-
fered IOL, dependent on the areas in which they live
and access maternity services.
Further research, such as the CHOICE Study, is crucial
for providing evidence to inform and support decision-
making by women and their care givers. In the future,
when COVID-19 is no longer a factor in clinical
decision-making, changes to practice made during the
pandemic should be scrutinised within the context of
this new evidence.
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